# Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/quality-of-life-in-patients-with-recurrent-ovarian-cancer-treated-with-niraparib/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Amit M. Oza,Ursula A. Matulonis,Susanne Malander,Stacie Hudgens,Jalid Sehouli,Josep M. del Campo,Dominique Berton-Rigaud,Susana Banerjee,Giovanni Scambia,Jonathan S. Berek,Bente Lund,Anna V. Tinker,Felix Hilpert,Isabel Palacio Vázquez,Véronique D’Hondt,Benedict B. Benigno,Diane Provencher,Joseph Buscema,Shefali Agarwal,Mansoor Raza Mirza |
| Citations | 126 |
| DOI | 10.1016/s1470-2045(18)30333-4 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2884001607 |
| PMID | 30026000 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Stacie Hudgens](https://scholariq.org/researchers/stacie-hudgens/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.